POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in POINT Biopharma Global Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +22 vs. Q2 2022
- Shares held
- 60.9M
- +12.3M (+25.4%) vs. Q2 2022
- Total value
- $470.4M
- +$140.0M (+42.4%) vs. Q2 2022
- New holders
- 32
- 40 more added
- Sold out
- 10
- 21 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 126 | $411.0M |
| Q2 2023 | 130 | $570.6M |
| Q1 2023 | 115 | $455.0M |
| Q4 2022 | 109 | $445.5M |
| Q3 2022 | 106 | $470.4M |
| Q2 2022 | 84 | $330.5M |
| Q1 2022 | 68 | $318.0M |
| Q4 2021 | 55 | $194.4M |
| Q3 2021 | 34 | $247.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding POINT Biopharma Global Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 3,679,997 | $28.4M | 0.04% | +1,369,820+59.3% | Added |
| Point72 Asset Management, L.P. | 3,692,620 | $28.5M | 0.12% | +1,738,391+89.0% | Added |
| Vanguard Group Inc | 3,875,322 | $30.0M | 0.00% | +426,617+12.4% | Added |
| PFM Health Sciences, LP | 4,515,216 | $34.9M | 1.34% | +4,515,216 | New |
| BVF Inc | 5,590,048 | $43.2M | 1.78% | +2,222,222+66.0% | Added |
| BlackRock Inc. | 6,152,597 | $47.6M | 0.00% | +16,099+0.3% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −9,003,018−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −490,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −308,236−100.0% | Sold out |
| Oracle Investment Management Inc | 0 | $0 | 0.00% | −129,810−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −33,244−100.0% | Sold out |
| Clarkston Capital Partners, LLC | 0 | $0 | 0.00% | −22,545−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −19,480−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −11,395−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −3,606−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −210−100.0% | Sold out |